Evidence map›Paper›PMID 35782414›Full record

ArticleFrontiers in psychiatry2022

Mental Disorders Are Associated With Leukocytes Telomere Shortening Among People Who Inject Drugs.

Mélusine Durand, Nicolas Nagot, Laurent Michel, Sao Mai Le, Huong Thi Duong, Roselyne Vallo, Amélie Vizeneux, Delphine Rapoud, Hoang Thi Giang, Catherine Quillet and 9 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 3 countries.

Mélusine DurandPathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, University of Antilles, Montpellier, France.
Nicolas NagotPathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, University of Antilles, Montpellier, France.
Laurent MichelPierre Nicole Center, CESP UMR 1018, Paris-Saclay University, Paris, France.
Sao Mai LeFaculty of Public Health, Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.
Huong Thi DuongFaculty of Public Health, Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.
Roselyne ValloPathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, University of Antilles, Montpellier, France.
Amélie VizeneuxPathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, University of Antilles, Montpellier, France.
Delphine RapoudPathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, University of Antilles, Montpellier, France.
Hoang Thi GiangFaculty of Public Health, Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.
Catherine QuilletPathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, University of Antilles, Montpellier, France.
Nham Thi Tuyet ThanhSupporting Community Development Initiatives, Hanoi, Vietnam.
Khuat Thi Hai OanhSupporting Community Development Initiatives, Hanoi, Vietnam.
Vu Hai VinhInfectious and Tropical Diseases Department, Viet Tiep Hospital, Hai Phong, Vietnam.
Jonathan FeelemyerSchool of Global Public Health, New York University, New York, NY, United States.
Philippe Vande PerrePathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, University of Antilles, Montpellier, France.
Khue Pham MinhFaculty of Public Health, Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.
Didier LaureillardPathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, University of Antilles, Montpellier, France.
Don Des JarlaisSchool of Global Public Health, New York University, New York, NY, United States.
Jean-Pierre MolèsPathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, University of Antilles, Montpellier, France.
Inserm · FRCenter for Creative Initiatives in Health and Population · VNHai Phong University · VNHai phong University Of Medicine and Pharmacy · VNNew York University · USPathogenesis and Control of Chronic and Emerging InfectionsÉtablissement Français du Sang · FRHung Vuong Hospital · VNUniversité de Montpellier · FRUniversité Paris-Saclay · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Premature biological aging, assessed by shorter telomere length (TL) and mitochondrial DNA (mtDNA) alterations, has been reported among people with major depressive disorders or psychotic disorders. However, these markers have never been assessed together among people who inject drugs (PWIDs), although mental disorders are highly prevalent in this population, which, in addition, is subject to other aggravating exposures. Diagnosis of mental disorders was performed by a psychiatrist using the Mini International Neuropsychiatric Interview test among active PWIDs in Haiphong, Vietnam. mtDNA copy number (MCN), mtDNA deletion, and TL were assessed by quantitative PCR and compared to those without any mental disorder. We next performed a multivariate analysis to identify risk factors associated with being diagnosed with a major depressive episode (MDE) or a psychotic syndrome (PS). In total, 130 and 136 PWIDs with and without psychiatric conditions were analyzed. Among PWIDs with mental disorders, 110 and 74 were diagnosed with MDE and PS, respectively. TL attrition was significantly associated with hepatitis C virus-infected PWIDs with MDE or PS (adjusted odds ratio [OR]: 0.53 [0.36; 0.80] and 0.59 [0.39; 0.88], respectively). TL attrition was even stronger when PWIDs cumulated at least two episodes of major depressive disorders. On the other hand, no difference was observed in mtDNA alterations between groups. The telomeric age difference with drug users without a diagnosis of psychiatric condition was estimated during 4.2-12.8 years according to the number of MDEs, making this group more prone to age-related diseases.

Indexed as

agingdepressiondrug usehepatitis C virusmitochondrial DNApsychotic syndrometelomere shortening

Identifiers

PMID35782414
PMCPMC9247253
OpenAlexW4283018947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.